Table 2 Postoperative outcome
Post-operative outcome | N (%) |
|---|---|
Location of Iluvien implant (quadrant) | |
Superior Supero-temporal Inferior Infero-temporal | 9 (75) 1 (8.3) 1 (8.3) 1 (8.3) |
Follow-up (months) | |
12 > 12–24 > 24 | 7 (58.3) 4 (33.3) 1 (8.3) |
Final BCVA (decimal) | |
˂0.1 0.1–0.5 > 0.5 | 6 (50) 5 (42) 1 (8.3) |
Final CMT (µ) | |
< 400 400–600 > 600 | 6 (50) 4 (33.3) 2 (17) |
Final IOP (mmHg) | |
˂15 15–20 > 20 | 0 (0) 10 (83.3) 2 (17) |
Complications | |
Transient IOP spike Nuclear sclerosis grade I | 6 (50) 2 (20) |